Vaxcyte to Present at Jefferies Virtual London Healthcare Conference

NEXT STORY
Zai Lab Partner Five Prime Therapeutics Announces Bemarituzumab Plus Chemotherapy Demonstrates Significant Progression-Free and Overall Survival Benefit Compared to Placebo Plus Chemotherapy in Front-Line Advanced Gastric or Gastroesophageal Junction Cancer
PREV STORY
Turning Point Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older

author_avatar
NASDAQ Market News

Zai Lab Limited Announces Pricing of U.S. Initial Public Offering of ADSs

NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces ...

author_avatar
NASDAQ Market News

Brandywine Realty Trust Announces First Quarter Results And Narrows 2021 Guidance

author_avatar
NASDAQ Market News